Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France

por Limosin, Frédéric, Belhadi, Drifa, Comet, Denis, Pacou, Maud, Bouju, Sophie, Van Impe, Kristel, Guillon, Pascal
Publicado 2018

Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France

por Druais, Sylvain, Doutriaux, Agathe, Cognet, Magali, Godet, Annabelle, Lançon, Christophe, Levy, Pierre, Samalin, Ludovic, Guillon, Pascal
Publicado 2016

Assessment of risk factors of treatment discontinuation among patients on paliperidone palmitate and risperidone microspheres in France, Germany and Belgium

por Cai, Rui, Decuypere, Flore, Chevalier, Pierre, Desseilles, Martin, Lambert, Martin, Fakra, Eric, Wimmer, Antonie, Guillon, Pascal, Pype, Stefan, Godet, Annabelle, Borgmeier, Valeria
Publicado 2022